Isolation and partial structure determination of a clonidine-displacing substance from bovine lung and brain.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the Autonomic Nervous System

• Publication date

  1998-10-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0165-1838(98)00092-7PMID 9851556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung

  2004cited by this paper
• Characterization of non-adrenergic [3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands

  1995cited by this paper
• Optimization of Radioligand Binding Assays for I1‐Imidazoline Sites fn1

  1995cited by this paper
• I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling.

  1995cited by this paper
• Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats

  1995cited by this paper
• Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.

  1995cited by this paper
• Imidazoline Receptors and Sodium Excretion in the Rat Kidney fn1

  1995cited by this paper
• Distribution of Nonadrenergic [3H]Rilmenidine Binding in Rat Brain and Kidney a

  1995cited by this paper
• I1‐Imidazoline Receptors

  1995cited by this paper
• Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.

  1994cited by this paper
• Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system

  1994cited by this paper
• Potential Role of Imidazoline (I1) Receptors in Modulating Aqueous Humor Dynamics

  1994cited by this paper
• Agmatine: an endogenous clonidine-displacing substance in the brain.

  1994cited by this paper
• Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid.

  1993cited by this paper
• Keeping an eye on the I site: imidazoline-preferring receptors.

  1992cited by this paper
• Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.

  1992cited by this paper
• From the alpha 2-adrenoceptors to the imidazoline preferring receptors.

  1992cited by this paper
• Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion.

  1992cited by this paper
• Keeping an eye on the I site: imidazoline-prefemng receptors

  1992cited by this paper
• Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane.

  1991cited by this paper
• Effect of clonidine on catechol metabolism in the rostral ventrolateral medulla: an in vivo electrochemical study.

  1991cited by this paper
• Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.

  1991cited by this paper
• Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.

  1991cited by this paper
• Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aorta.

  1991cited by this paper
• Agmatine acts as an antagonist of neuronal nicotinic receptors

  1990cited by this paper
• Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors.

  1990cited by this paper
• Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha‐2-adrenergic receptors in the rostral ventrolateral medulla

  1988cited by this paper
• An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.

  1986cited by this paper
• An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.

  1986cited by this paper
• Isolation and partial purification of a clonidine-displacing endogenous brain substance.

  1984cited by this paper
• Measurement of protein in cell suspensions using the Coomassie brilliant blue dye-binding assay.

  1982cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Borne Identity: Leading Endogenous Suspects at Imidazoline Binding Sites

  2015cites this paper
• Imidazoline binding sites and their ligands: An overview of the different chemical structures

  2004cites this paper
• Imidazoleacetic acid-ribotide: an endogenous ligand that stimulates imidazol(in)e receptors.

  2004cites this paper
• Harmane and harmalan are bioactive components of classical clonidine-displacing substance.

  2004cites this paper
• Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

  2001cites this paper
• Harmane produces hypotension following microinjection into the RVLM: possible role of I1‐imidazoline receptors

  2000cites this paper
• Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells.

  2000cites this paper
• Imidazoline receptors: new targets for antihyperglycaemic drugs.

  1999cites this paper
• Recent advances in imidazoline receptor research: ligands--localization and isolation--signaling--functional and clinical studies.

  1998cites this paper